We ship discreetly in insulated mailers, with free delivery on orders over $200 and a batch-matched COA available on request
Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to GLP3 research and development
doi:10.1056/NEJMoa2301972 PubMed: This landmark study demonstrated 24.2% mean weight loss at 48 weeks with the 12mg dose in 338 adults with obesity, establishing retatrutide as the most effective obesity medication tested to date
GLP-1 increases insulin release, decreases glucagon, slows stomach emptying, and enhances satiety to control blood sugar
Yes, orforglipron (Foundayo) is effective for weight loss in non-diabetics
It works by targeting three pathways as opposed to one for semaglutide and two for tirzepatide, creating a powerful effect on appetite and blood sugar regulation